News
Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser (OSD) has found its first application for the treatment of dry eye with the launch of VISMED® MULTI.
Aptar Pharma has worked closely with the Swiss-German based Eye Care specialist TRB Chemedica for improving patient safety, achieving dosing accuracy and maintaining product stability on the ophthalmic spray device.
Aptar Pharma meets the needs of patients
Dry eye patients instill regularly lubricant eye drops, and often for the rest of their life. Most of
these patients are elderly and experience difficulties when using preservative-free multidose
dispensers, since dispensing systems currently available do not offer overall satisfaction for
eye drop delivery.
In particular, the fact that preservatives can be omitted with Aptar Pharma’s OSD system, is well
appreciated by the high number of patients experiencing eye irritation or allergic responses with
preserved formulations.
Making ophthalmic solutions easier and safer to delive
Aptar Pharma’s OSD system is the result of more than 10 years of development for the delivery of preservative-free ophthalmic solutions.
TRB Chemedica's new VISMED® MULTI, a patented, sterile, hypotonic lubricant eye drops formulation of 0.18 % hyaluronic acid with essential ions calcium, magnesium potassium contains 10 ml of solution, equivalent to more than 250 drops and remains sterile for up to 3 months after first use.
For this solution, Aptar Pharma’s OSD system highlights the following features: • intrinsic intuitiveness of a squeezable container • user friendliness for all adult age groups due to a low actuation force • precise and reproducible drop ejection • ergonomic and pocket size design
Staying ahead of the market
With choosing the worldwide trend towards safe, patient-friendly, cost-effective and preservative-free multidose dispensers such as Aptar Pharma's OSD system, VISMED® MULTI is able to maintain its status as the gold standard in lubricant eye drops.
Aptar Pharma is part of the Aptargroup family of companies, along with Aptar Beauty + Home and Aptar Food + Beverage. We create innovative drug delivery systems that meet the evolving needs of biotechnology, healthcare and pharmaceutical companies around the world. We provide our customers with a wide range of delivery technologies and analytical services backed by years of proven expertise. Aptargroup (NYSE: ATR) is headquartered in the US and has manufacturing sites in North America, Europe, Asia and South America. For more information, visit www.aptar.com.
Marion Baschet Vernet Tel.: +44 (0)797 609 4100 Email : mbvernet@gmail.com
Download the press release in PDF format < Back